(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Ligand Pharmaceuticals is 256890
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 196.08 | 197.57 | 199.35 | 190.98 | 1.284 times |
| 14 Wed Jan 2026 | 196.54 | 188.38 | 197.49 | 186.26 | 1.112 times |
| 13 Tue Jan 2026 | 188.78 | 196.96 | 199.00 | 175.89 | 3.658 times |
| 12 Mon Jan 2026 | 206.81 | 207.82 | 210.27 | 205.25 | 1.132 times |
| 09 Fri Jan 2026 | 206.65 | 200.01 | 206.94 | 197.91 | 0.735 times |
| 08 Thu Jan 2026 | 200.07 | 200.24 | 204.86 | 197.04 | 0.459 times |
| 07 Wed Jan 2026 | 199.96 | 197.42 | 206.44 | 194.78 | 0.708 times |
| 06 Tue Jan 2026 | 196.02 | 192.02 | 197.02 | 189.88 | 0.562 times |
| 05 Mon Jan 2026 | 192.03 | 189.43 | 193.00 | 187.08 | 0.489 times |
| 02 Fri Jan 2026 | 190.11 | 188.60 | 192.48 | 186.48 | 0.801 times |
My analysis of stock is bearish for shortterm, and stock might move down till 191.6 or till 185.7. Use a stoploss of 196.46 and if the stock hits stoploss, then it can shoot up till 201.34
Share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Target | 160.80 |
| Downside Target | 175.56 |
| Downside Target | 186.28 |
| Downside Target | 194.44 |
| Downside Target | 196.04 |
| Upside Target | 202.50 |
| Upside Target | 202.97 |
| Upside Target | 206.94 |
| Upside Target | 210.27 |
| Upside Target | 212.49 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Intraday Target | 177.89 |
| Downside Intraday Target | 159.7 |
| Upside Intraday Target | 212.27 |
| Upside Intraday Target | 228.46 |
| Downside Intraday Target | 194.08 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 196.08 | 207.82 | 210.27 | 175.89 | 2.434 times |
| 09 Fri Jan 2026 | 206.65 | 189.43 | 206.94 | 187.08 | 1.22 times |
| 02 Fri Jan 2026 | 190.11 | 196.00 | 196.04 | 186.48 | 1.446 times |
| 26 Fri Dec 2025 | 195.83 | 200.89 | 202.97 | 194.44 | 0.296 times |
| 19 Fri Dec 2025 | 200.33 | 190.44 | 202.50 | 188.69 | 1.31 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 196.08 | 188.60 | 210.27 | 175.89 | 0.615 times |
| 31 Wed Dec 2025 | 189.07 | 199.88 | 202.97 | 179.65 | 1.057 times |
| 28 Fri Nov 2025 | 203.18 | 188.20 | 212.49 | 186.28 | 1.221 times |
| 31 Fri Oct 2025 | 191.31 | 176.68 | 194.44 | 175.56 | 0.725 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Ligand Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 195.3 and Ligand Pharmaceuticals (LGND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Ligand Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 195.3 and Ligand Pharmaceuticals (LGND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.